Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic Cancer von Levink, Iris J M, Jansen, Maurice P H M, Azmani, Zakia, van IJcken, Wilfred, van Marion, Ronald, Peppelenbosch, Maikel P, Cahen, Djuna L, Fuhler, Gwenny M, Bruno, Marco J

Volltext

Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer von Vitale, Silvia R., Helmijr, Jean A., Gerritsen, Marjolein, Coban, Hicret, van Dessel, Lisanne F., Beije, Nick, van der Vlugt-Daane, Michelle, Vigneri, Paolo, Sieuwerts, Anieta M., Dits, Natasja, van Royen, Martin E., Jenster, Guido, Sleijfer, Stefan, Lolkema, Martijn, Martens, John W. M., Jansen, Maurice P. H. M.

Volltext

Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels von Jongbloed, Elisabeth M., Jansen, Maurice P. H. M., de Weerd, Vanja, Helmijr, Jean A., Beaufort, Corine M., Reinders, Marcel J. T., van Marion, Ronald, van IJcken, Wilfred F. J., Sonke, Gabe S., Konings, Inge R., Jager, Agnes, Martens, John W. M., Wilting, Saskia M., Makrodimitris, Stavros

Volltext

Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients von Valle-Inclan, Jose Espejo, Stangl, Christina, de Jong, Anouk C., van Dessel, Lisanne F., van Roosmalen, Markus J., Helmijr, Jean C. A., Renkens, Ivo, Janssen, Roel, de Blank, Sam, de Witte, Chris J., Martens, John W. M., Jansen, Maurice P. H. M., Lolkema, Martijn P., Kloosterman, Wigard P.

Volltext

TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer von Vitale, Silvia R., Groenendijk, Floris H., van Marion, Ronald, Beaufort, Corine M., Helmijr, Jean C., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Ewing-Graham, Patricia C., Smolders, Ramon, van Doorn, Helena C., Boere, Ingrid A., Berns, Els M. J. J., Helleman, Jozien, Jansen, Maurice P. H. M.

Volltext

Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNA von Weerts, Marjolein J. A., van Marion, Ronald, Helmijr, Jean C. A., Beaufort, Corine M., Krol, Niels M. G., Trapman-Jansen, Anita M. A. C., Dinjens, Winand N. M., Sleijfer, Stefan, Jansen, Maurice P. H. M., Martens, John W. M.

Volltext

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients von Reijm, Esther A, Sieuwerts, Anieta M, Smid, Marcel, Vries, Joan Bolt-de, Mostert, Bianca, Onstenk, Wendy, Peeters, Dieter, Dirix, Luc Y, Seynaeve, Caroline M, Jager, Agnes, de Jongh, Felix E, Hamberg, Paul, van Galen, Anne, Kraan, Jaco, Jansen, Maurice P H M, Gratama, Jan W, Foekens, John A, Martens, John W M, Berns, Els M J J, Sleijfer, Stefan

Volltext

The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer von Vitale, Silvia R, Ruigrok-Ritstier, Kirsten, Timmermans, A Mieke, Foekens, Renée, Trapman-Jansen, Anita M A C, Beaufort, Corine M, Vigneri, Paolo, Sleijfer, Stefan, Martens, John W M, Sieuwerts, Anieta M, Jansen, Maurice P H M

Volltext

Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer von Xu, Tong, Verhagen, Mathijs P., Teeuwssen, Miriam, Sun, Wenjie, Joosten, Rosalie, Sacchetti, Andrea, Ewing-Graham, Patricia C., Jansen, Maurice P. H. M., Boere, Ingrid A., Bryce, Nicole S., Zeng, Jun, Treutlein, Herbert R., Hook, Jeff, Hardeman, Edna C., Gunning, Peter W., Fodde, Riccardo

Volltext

Hallmarks of Aromatase Inhibitor Drug Resistance Revealed by Epigenetic Profiling in Breast Cancer von JANSEN, Maurice P. H. M, KNIJNENBURG, Theo, FOEKENS, John A, WESSELS, Lodewyk, LINN, Sabine C, BERNS, Els M. J. J, ZWART, Wilbert, REIJM, Esther A, SIMON, Iris, KERKHOVEN, Ron, DROOG, Marjolein, VELDS, Arno, VAN LAERE, Steven, DIRIX, Luc, ALEXI, Xanthippi

Volltext

IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer von Zhang, Yinghui, Wester, Lynn, He, Jichao, Geiger, Tamar, Moerkens, Marja, Siddappa, Ram, Helmijr, Jean A., Timmermans, Mieke M., Look, Maxime P., van Deurzen, Caroline H. M., Martens, John W. M., Pont, Chantal, de Graauw, Marjo, Danen, Erik H. J., Berns, Els M. J. J., Meerman, John H. N., Jansen, Maurice P. H. M., van de Water, Bob

Volltext

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients von Beije, Nick, Sieuwerts, Anieta M., Kraan, Jaco, Van, Ngoc M., Onstenk, Wendy, Vitale, Silvia R., Vlugt‐Daane, Michelle, Dirix, Luc Y., Brouwer, Anja, Hamberg, Paul, Jongh, Felix E., Jager, Agnes, Seynaeve, Caroline M., Jansen, Maurice P. H. M., Foekens, John A., Martens, John W. M., Sleijfer, Stefan

Volltext

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA von Bos, Manouk K., Nasserinejad, Kazem, Jansen, Maurice P. H. M., Angus, Lindsay, Atmodimedjo, Peggy N., Jonge, Evert, Dinjens, Winand N. M., Schaik, Ron H. N., Del Re, Marzia, Dubbink, Hendrikus J., Sleijfer, Stefan, Martens, John W. M.

Volltext

High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms von Dessel, Lisanne F., Vitale, Silvia R., Helmijr, Jean C. A., Wilting, Saskia M., Vlugt‐Daane, Michelle, Oomen‐de Hoop, Esther, Sleijfer, Stefan, Martens, John W. M., Jansen, Maurice P. H. M., Lolkema, Martijn P.

Volltext

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen von Kok, Marleen, Linn, Sabine C., Van Laar, Ryan K., Jansen, Maurice P. H. M., van den Berg, Teun M., Delahaye, Leonie J. M. J., Glas, Annuska M., Peterse, Johannes L., Hauptmann, Michael, Foekens, John A., Klijn, Jan G. M., Wessels, Lodewyk F. A., Van’t Veer, Laura J., Berns, Els M. J. J.

Volltext

RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer von Helden, Erik J., Angus, Lindsay, Menke‐van der Houven van Oordt, C. Willemien, Heideman, Daniëlle A. M., Boon, Eline, Es, Suzanne C., Radema, Sandra A., Herpen, Carla M. L., Groot, Derk Jan A., Vries, Elisabeth G. E., Jansen, Maurice P. H. M., Sleijfer, Stefan, Verheul, Henk M. W.

Volltext

Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer von Jansen, Maurice P. H. M, Ruigrok-Ritstier, Kirsten, Dorssers, Lambert C. J, van Staveren, Iris L, Look, Maxime P, Meijer-van Gelder, Marion E, Sieuwerts, Anieta M, Helleman, Jozien, Sleijfer, Stefan, Klijn, Jan G. M, Foekens, John A, Berns, Els M. J. J

Volltext

Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen von Ramirez-Ardila, Diana E., Helmijr, Jean C., Look, Maxime P., Lurkin, Irene, Ruigrok-Ritstier, Kirsten, van Laere, Steven, Dirix, Luc, Sweep, Fred C., Span, Paul N., Linn, Sabine C., Foekens, John A., Sleijfer, Stefan, Berns, Els M. J. J., Jansen, Maurice P. H. M.

Volltext

TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer von Meijer, Danielle, Jansen, Maurice P. H. M, Look, Maxime P, Ruigrok-Ritstier, Kirsten, van Staveren, Iris L, Sieuwerts, Anieta M, van Agthoven, Ton, Foekens, John A, Dorssers, Lambert C. J, Berns, Els M. J. J

Volltext

HOXB13-to-IL17BR Expression Ratio Is Related With Tumor Aggressiveness and Response to Tamoxifen of Recurrent Breast Cancer: A Retrospective Study von JANSEN, Maurice P. H. M, SIEUWERTS, Anieta M, LOOK, Maxime P, RITSTIER, Kirsten, MEIJER-VAN GELDER, Marion E, VAN STAVEREN, Iris L, KLIJN, Jan G. M, FOEKENS, John A, BERNS, Els M. J. J

Volltext